Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aluminum hydroxide (Gaviscon) (1 trial)
influenza vlp vaccine (1 trial)
Communicable Diseases (Phase 1)
Infections (Phase 1)
Influenza, Human (Phase 1)
Respiratory Tract Diseases (Phase 1)
Respiratory Tract Infections (Phase 1)
RNA Virus Infections (Phase 1)
Virus Diseases (Phase 1)
Trials (1 total)
Trial APIs (2 total)